About
Oncgnostics GmbH is a molecular diagnostics company specializing in the development of in-vitro diagnostic tests for early detection and diagnosis of cancers, particularly cervical cancer, using patented DNA methylation biomarkers.
Explore oncgnostics GmbH's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.